Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
1 kopie van APOE3 Christchurch-variant vertraagt autosomaal dominante ziekte van Alzheimer
aug 2024 | Dementie